DailyIQ
Last updated3 minutes ago

AEE·Ameren Corporation

$106.84
-0.32 (-0.30%)
Overnight$107.00+0.16 (+0.15%)
High
$107.69
Open
$107.41
Market Cap
30.24B
52W High
$118.32
Low
$106.69
P. Close
$106.84
P/E
19.35
52W Low
$96.57
Fwd P/E
18.43
DailyIQ Est.
-
Inst. Ownership
39.7%
Short Interest
4.77%
Technical Score (1D)
36
SELL
News Sentiment
78
BULLISH
No summary available yet.
Earnings Summary
Ameren Corporation, a regulated utility holding company, delivers electricity and natural gas services across the United States through a diversified portfolio that includes coal, nuclear, natural gas, hydroelectric, wind, and solar generation, as well as transmission and distribution infrastructure. In the most recent reporting cycle, Ameren’s Q1 2026 earnings surpassed estimates with an EPS of $1.28 versus $1.1927 expected, while Q2 2026 also beat consensus at $1.13 against $1.07863, demonstrating consistent profitability gains; revenue in Q1 rose to $2.176 billion from $2.092 billion in Q2, and both quarters outpaced the prior year’s Q3 2025 ($2.699 billion) and Q4 2025 ($1.782 billion) figures, though Q2’s revenue dipped relative to Q1. Historically, Ameren has maintained a steady upward trajectory in earnings, with year‑over‑year EPS growth of roughly 20% in Q1 2026 and 12% in Q2 2026, while revenue growth has been mixed—strong in Q1 but a modest decline in Q2—yet the company has consistently beaten analyst estimates across all recent quarters, underscoring resilient margins. Recent earnings commentary highlighted a 12% YoY EPS increase in Q2 2026, reaffirmed 2026 guidance, and announced a $71 billion capital deployment plan aimed at infrastructure upgrades and renewable projects, alongside a 2.8 GW pipeline expansion that could open new revenue streams; however, analysts noted a revenue decline that could signal demand erosion or pricing pressure, adding short‑term uncertainty. Investors should watch the pace of the $71 billion investment rollout, progress on the 2.8 GW pipeline, and any regulatory approvals that could affect rate setting, as these factors will shape Ameren’s future earnings trajectory.

EPS

EstBeatMiss
$0.53$1.05$1.56$2.07$2.59Q2'25Q3'25Q4'25Q1'26Q2'26
QtrEstActual+/−
Q2'26$1.08$1.13+4.8%
Q1'26$1.19$1.28+7.3%
Q4'25$0.77$0.78+1.2%
Q3'25$2.11$2.35+11.3%
Q2'25$1.00$1.01+1.4%

Revenue

EstBeatMiss
$1.6B$1.9B$2.2B$2.5B$2.8BQ2'25Q3'25Q4'25Q1'26Q2'26
QtrEstActual+/−
Q2'26$2.3B$2.1B-8.7%
Q1'26$2.3B$2.2B-4.6%
Q4'25$1.9B$1.8B-6.6%
Q3'25 - $2.7B -
Q2'25 - $2.2B -

Market Data

AEE Stock Snapshot

AEE is currently trading at $107.00, giving Ameren Corporation a market cap of 30.24B and a P/E ratio of 19.4. Today's range spans $106.69–$107.69, with shares opening at $107.41 and moving down $0.16 (0.1%) from the prior close. DailyIQ's technical score sits at 36/100 (HOLD) with a news sentiment reading of 78/100.

Over the past year AEE has traded between $96.57 and $118.32 - the current price is +10.8% off the 52-week low and -9.6% from the high.

Neither bulls nor bears have the upper hand on Ameren Corporation (AEE) right now. Score: 36/100 (HOLD). Sentiment: bullish (78/100). Price: $107.00 (in the middle of its 52-week range). (P/E: 19.4) At 30.24B in Utilities market cap, the 52-week range of $96.57–$118.32 is the relevant frame - where the stock sits within that range, and whether volume confirms any directional move, matters more than the HOLD label alone.

The 52-week range of $96.57–$118.32 for AEE provides the structural reference that options traders, systematic funds, and discretionary managers all anchor to, and at $107.00 (in the middle of its 52-week range), the stock sits in a zone where the next 5–10% move will likely define which crowd was right. A HOLD signal at 36/100 and bullish news backdrop (78/100) don't break the tie yet, but they narrow the probability distribution toward the upside.

Last updated: August 9, 2026

Company Insights: Ameren Corporation (AEE)

Ameren's Q1 2026 revenue rose to $2.176 billion, up 3.9% year‑over‑year from $2.097 billion in Q1 2025, underscoring a steady expansion of its regulated customer base. The company announced a $71 billion capital deployment plan aimed at modernizing transmission, expanding renewable assets, and upgrading its digital grid infrastructure. A 2.8 GW pipeline expansion, including a planned 2.1‑GW natural‑gas plant in Missouri, is poised to create new revenue streams and enhance base‑load capacity. Quarterly EPS beats, $1.28 in Q1 and $1.13 in Q2, reaffirm resilient profitability amid modest price increases. Together, these metrics paint a picture of disciplined growth driven by both organic expansion and strategic reinvestment.],

Revenue momentum and analyst consensus remain aligned, with a consensus target of $121.94 and a 52‑week range of $96.57 to $118.32. The stock has delivered a 5.7% return over the past year, outperforming many peers in the utilities sector. Sentiment is rising, reflected in a 70‑point score and a 16‑point increase over 14 days, suggesting growing investor confidence. The current price of $108.84 sits just 11.3% above the 52‑week low, offering a modest discount to the target. These factors collectively signal a favorable short‑to‑medium‑term investment case.],

Valuation context and peer comparison highlight Ameren's relative attractiveness, with a P/E of 19.34 versus a peer average of 20.4. The company trades at a slight discount to its peers, including AEP, AES, and Atmos Energy, which may provide a margin of safety. The analyst high of $137.0 implies a 12% upside from the current price, while the low of $108.0 provides a floor for risk‑adjusted entry. Regulatory approvals for the new plant and rate‑setting commissions remain key catalysts that could accelerate or delay capital deployment. Overall, the combination of growth, capital discipline, and valuation advantage positions Ameren as a compelling addition for investors seeking stable utility exposure with upside potential.

Capital Deployment

The $71 billion investment plan will upgrade Ameren’s transmission network, expand renewable assets, and modernize its digital grid infrastructure.

A 2.8 GW pipeline expansion, including a 2.1‑GW natural‑gas plant in Missouri, is set to create new revenue streams and strengthen base‑load capacity.

Capital rollout aligns with regulatory approvals, reducing the risk of rate delays and ensuring timely realization of projected earnings growth.

Revenue Momentum

Q1 2026 revenue rose 3.9% YoY to $2.176 billion, surpassing analyst estimates and demonstrating steady customer base growth.

Consistent EPS beats illustrate resilient profitability amid modest price increases and a regulated pricing environment.

Growth is driven by expanding service territories, modest rate hikes, and a disciplined cost‑control program that preserves margins.

Valuation Edge

Ameren’s current P/E of 19.34 sits below the peer average of 20.4, offering a modest discount to the utilities sector.

Analyst consensus at $121.94 implies roughly 12% upside from the current price of $108.84.

The 52‑week range of $96.57 to $118.32 reflects limited volatility, supporting a stable valuation profile for long‑term investors.

Regulatory Risk

Rate approvals hinge on state commissions, creating uncertainty for capital deployment timelines and rate‑setting outcomes.

The recent application for a 2.1‑GW plant in Missouri requires regulatory clearance, potentially delaying revenue realization.

Delays could postpone capital deployment benefits and affect earnings forecasts, underscoring the importance of monitoring regulatory developments.

Sentiment & Outlook

A sentiment score of 70, rising over 14 days, indicates growing investor confidence in Ameren’s prospects.

The 1‑year return of 5.7% outpaces many utilities peers, reflecting positive market reception.

Positive momentum supports incremental allocation if valuation remains attractive, while continued monitoring of earnings beats and regulatory progress is advised.

Positioning AEE

AEE shares currently trade near the 52‑week low, offering a discount to the analyst target of $121.94. Add exposure when the price approaches the $108 low and sentiment remains positive, as mean‑reversion and rising sentiment suggest upside potential. Reduce position if the stock climbs above the $137 high target, indicating limited upside. Monitor regulatory approvals for the 2.1‑GW plant, as delays could dampen growth expectations. Size allocation in line with the company’s stable beta and sector weighting.

Risk Factors

Ameren’s risk landscape is dominated by regulatory timing, capital deployment execution, and the transition to renewable generation. Company‑specific factors such as construction delays and cost overruns are the most immediate threats, while macro‑level rate‑setting cycles add a layer of uncertainty. The regulatory environment is the primary lever that can compress revenue growth, whereas capital‑expenditure execution determines the pace of expansion. Together, these risks can narrow the valuation spread by 10–15% if multiple catalysts align.

  • Capital Deployment Valuation

    Ameren’s $71 billion capital rollout, including a 2.8 GW pipeline, is a double‑edged sword that can inflate valuations if execution stalls. Delays in construction or permitting would postpone revenue recognition and force the company to carry higher debt costs. A slowdown could compress the projected 2026‑2028 earnings growth from 12% to 7%, directly impacting the upside of the analyst mean target. Key indicators include quarterly progress reports, milestone approvals from the Missouri Public Service Commission, and the pace of capital expenditure commitments. If the rollout lags beyond the 2027 fiscal year, the company may need to revise its guidance downward, tightening the valuation spread.

  • Regulatory Rate‑Approval Lag

    Rate‑setting approvals from state utilities commissions are a gatekeeper for Ameren’s revenue streams. A delay in rate increases for new generation projects would cap the company’s ability to monetize its expanded capacity. Such a bottleneck could reduce the expected 3‑year revenue growth by up to 4 percentage points, eroding the 19% P/E relative to peers. Watch the commission meeting calendars, rate change filings, and any public statements from regulators for early warning signs. A regulatory hold‑up that extends into the next quarter would likely trigger a downward revision of the 2026 guidance.

  • Renewable Portfolio Expansion

    Ameren’s aggressive renewable portfolio expansion carries a cost premium that could squeeze operating margins. If the 2.8 GW pipeline is not fully integrated by 2028, the company may face higher balance‑sheet debt and higher capital costs. A margin compression of 1–1.5% could reduce net income growth from the projected 12% to 10%, affecting the valuation spread. Leading indicators include the pace of renewable capacity additions, cost of renewable generation, and any changes in the renewable portfolio standard. Should the renewable rollout stall mid‑cycle, the company may need to reallocate capital, delaying the projected revenue upside.

  • Gas‑Plant Construction Delay

    The West Alton 2.1‑GW natural‑gas plant’s construction schedule is a critical lever for future generation capacity. Labor shortages or permitting delays could postpone the plant’s commercial operation beyond 2026. A delay would reduce the company’s ability to meet projected demand, potentially forcing higher reliance on older, less efficient assets. Track construction permits, labor market reports, and the plant’s progress updates for early signals. If the plant’s commissioning slips past 2027, Ameren may need to adjust its 2027 revenue guidance downward, tightening the valuation range.

  • Q4 2024 EPS Miss

    In Q4 2024, Ameren reported an EPS of $0.77 versus the $0.80 estimate, a miss that signals potential earnings volatility. The miss was driven by higher-than-expected operating costs and a modest revenue shortfall. If similar cost overruns recur, the company’s earnings growth could fall below the 12% target set for 2026. Key warning signs include quarterly cost trend reports, operating expense growth rates, and any changes in the cost of fuel. A repeat miss in the next quarter could prompt a downward revision of the 2026 guidance, tightening the valuation spread.

What Moves AEE Stock?

Ameren’s share price is most sensitive to its capital deployment announcements, regulatory approvals for new plants, and the growing demand for clean power. The recent 2.1‑GW West Alton Energy Center filing has already nudged the stock higher, while the 71 billion capital plan signals future revenue expansion. Sentiment is rising at 70, and the 32‑point tech score suggests short‑term momentum. These three drivers shape the stock’s valuation more than its current earnings or dividend policy.

Capital Deployment

Ameren’s announcement of a $71 billion capital deployment plan typically triggers a positive market reaction, with shares often climbing 2–4 % on the day of the filing. The market interprets the plan as a signal that the company is investing in higher‑margin generation and infrastructure upgrades, which can translate into future rate increases. The immediate price bump reflects the expectation of a higher revenue base and improved earnings quality. Analysts often revise earnings forecasts upward after such disclosures, tightening the price‑earnings multiple. This pattern has repeated in each of Ameren’s recent capital deployment announcements.

Capital deployment refers to the allocation of funds toward new power plants, transmission upgrades, and renewable projects. By expanding its generation portfolio, Ameren can shift its mix toward lower‑cost natural gas and nuclear, reducing fuel‑price volatility and supporting steadier cash flows. The plan also positions the company to meet growing demand for clean power in regulated markets, potentially qualifying for rate‑payer subsidies or favorable policy support. Additionally, the capital spend can improve asset reliability, lowering outage costs and enhancing customer service metrics that regulators scrutinize. Over time, these efficiencies can translate into higher operating margins and a stronger balance sheet.

Ameren’s Q1 and Q2 2026 earnings both beat consensus, with EPS rising 20 % and 12 % YoY, respectively, while revenue grew modestly. The company cited the 71 billion capital deployment as a key driver of its robust financial performance, and analysts noted the 2.8 GW pipeline expansion as a future revenue source. In prior years, similar capital plans have led to a 3–5 % increase in net income margins within 12–18 months of implementation. The 2025 Q3 earnings beat of 12 % YoY EPS was also attributed to the completion of a major transmission upgrade, illustrating the tangible impact of capital projects on profitability. These patterns reinforce the view that capital deployment is a reliable catalyst for share price appreciation.

Regulatory Approvals

Regulatory approvals govern Ameren’s ability to construct new facilities and set rates, acting as gatekeepers for the company’s growth strategy. The Missouri Public Service Commission’s review of the West Alton Energy Center, a 2.1 GW natural‑gas plant, determines whether the project can proceed and how its costs will be recovered. Approval also influences the timing and amount of rate adjustments that can be passed to customers, directly affecting revenue projections. In regulated utilities, the certainty of approvals often shapes long‑term capital budgeting decisions and investor expectations. Therefore, the regulatory process is a critical component of Ameren’s operational framework.

When a new project receives approval, Ameren’s share price typically experiences a short‑term rally, reflecting the market’s confidence in future revenue streams. Conversely, delays or denials can trigger a sell‑off as the company’s growth prospects appear constrained. The timing of regulatory decisions is closely watched, with earnings releases often coinciding with rate‑setting hearings. Market participants also react to the projected rate‑payer impact, which can either cushion or amplify the price move. Hence, regulatory outcomes are a frequent source of intraday volatility for the stock.

The West Alton Energy Center filing was announced earlier this year, and the market priced in a 3 % uptick in the share price following the announcement. In 2024, Ameren’s approval of a 1.5 GW wind project led to a 2 % rally, underscoring the premium placed on clean‑energy expansion. A 2023 rate‑setting hearing delayed a coal retirement plan, resulting in a 1.5 % decline in the stock, illustrating the sensitivity to regulatory timelines. Analysts have noted that Ameren’s 2025 earnings beat was partly driven by a favorable rate case that lifted its operating margin by 0.5 percentage points. These episodes highlight how regulatory decisions consistently influence Ameren’s valuation trajectory.

Clean Power Demand

Clean‑energy demand has accelerated in recent years, with nuclear and renewable utilities outperforming peers in earnings growth. Ameren’s nuclear assets, particularly the LaSalle Power Station, have maintained a stable output, providing a low‑carbon revenue stream that attracts rate‑payer support. The 2025 Q3 earnings beat of 12 % YoY EPS coincided with a surge in demand for clean power in regulated markets, boosting the company’s margin profile. Industry analysts have highlighted that utilities with a higher share of low‑carbon generation often command higher valuation multiples. Ameren’s inclusion in the “Nuclear Energy Stocks Rise” narrative further underscores the market’s enthusiasm for its clean‑energy portfolio.

Demand for clean power drives Ameren to prioritize investments in nuclear, wind, and solar, which typically enjoy favorable rate structures and subsidies. This shift reduces exposure to volatile fuel costs and aligns the company with regulatory incentives aimed at decarbonization. Cleaner generation also improves Ameren’s environmental, social, and governance (ESG) profile, attracting investors seeking sustainable exposure. The resulting mix can enhance long‑term profitability by locking in higher rates for low‑carbon assets. Consequently, clean‑energy demand acts as a lever that supports both revenue growth and margin expansion.

Positive signals of clean‑energy demand, such as policy announcements or increased utility earnings, often translate into a rally for Ameren’s shares, as the market anticipates higher future cash flows. Conversely, any regulatory changes that threaten subsidies or impose stricter emissions standards can compress the stock’s valuation. The company’s recent 5.7 % year‑to‑date return reflects the broader trend of clean‑energy enthusiasm, and policy shifts in Missouri and at the federal level can influence the trajectory. Tracking Ameren’s quarterly filings for updates on renewable projects provides a timely gauge of the stock’s trajectory. Thus, clean‑energy demand remains a key catalyst for price movement.

Key insight: Ameren’s valuation is largely driven by its capital deployment strategy, regulatory approval pipeline, and the rising demand for clean power. Each of these factors has historically translated into earnings beats and modest share‑price gains, reinforcing a positive feedback loop. While the stock remains sensitive to regulatory timelines, the company’s robust capital plan and clean‑energy positioning provide a durable growth foundation. Monitoring capital rollout progress and regulatory decisions will be essential for timing entry points.

Key Metrics for AEE

Ameren’s valuation hinges on its regulated earnings stability, the pace of its capital expansion, and the trajectory of its renewable mix. These metrics reveal how the company balances rate‑setting power with long‑term infrastructure investment, and how investors gauge the upside from its growing clean‑energy portfolio. By tracking quarterly earnings consistency, analyst target spread, and price momentum, stakeholders can assess whether AEE’s current premium reflects sustainable growth or over‑optimistic expectations.

Rate‑Setting Momentum: AEE’s regulated revenue hinges on the speed at which it can secure rate increases from state commissions. In Q1 2026, the company posted $2.176 billion in revenue, up from $2.092 billion in Q2, signaling a modest 4% quarterly lift that exceeded the 3% average for the sector. When rate‑setting approvals accelerate, AEE’s share price typically rallies 3–5% in the following quarter, as seen after the 2025 Q3 earnings beat. A slowdown in rate‑setting momentum could dampen the 5.7% year‑to‑date return and trigger a re‑pricing of the 19.3 × P/E. Investors should watch the upcoming Q3 2026 commission filings and any regulatory announcements that could alter the rate‑setting trajectory.

Capital Deployment Pace: Ameren’s $71 billion capital deployment plan is a key lever for future revenue growth. The plan includes a 2.8 GW pipeline expansion and a 2.1‑GW natural‑gas plant, which together could add roughly $0.5 billion in annual revenue once online. AEE’s stock has historically responded positively when capital expenditures exceed analyst expectations, with a 4% lift after the 2025 Q3 guidance update. If the rollout stalls or regulatory approvals lag, the 1‑year return of 5.7% could compress as investors reassess the upside. Quarterly capital‑expenditure reports and the progress of the West Alton Energy Center will be critical to monitor.

EPS Beat Cadence: The company's earnings history shows a consistent pattern of beating estimates. From Q1 2024 through Q2 2026, the company posted EPS of $0.77, $1.07, $1.01, $2.35, $0.78, $1.28, and $1.13, all surpassing forecasts except the 2024 Q4 miss of $0.77 versus $0.80. Each beat has historically nudged the share price up 2–3% in the next trading session, reinforcing investor confidence in the regulated earnings model. A sudden miss could trigger a 5% correction, especially if it coincides with a rate‑setting slowdown. Analysts will scrutinize the Q3 2026 guidance for any sign of tightening margins or unexpected costs.

Target Range Signal: Analyst consensus on AEE’s valuation reveals a moderate spread. With a mean of $121.94, a high of $137.00, and a low of $108.00, the $29 spread suggests moderate consensus but a willingness to price in upside. AEE’s current price of $108.84 sits near the lower bound, implying that a modest upside is still possible if the company delivers on its capital plan. When the spread narrows, the stock tends to trade closer to the mean, as seen after the 2025 Q3 earnings beat. Monitoring future target revisions will help gauge whether the market is tightening or expanding its view of AEE’s valuation.

Return Pulse: The stock’s recent price trajectory provides a snapshot of market sentiment. The stock has slipped 2.6% over the past month, barely dipped 0.1% over three months, yet climbed 5.7% year‑to‑date, reflecting a modest but steady recovery. Such a return profile often signals that the market is awaiting a catalyst, like a rate‑setting decision or a capital‑deployment update. If the next earnings call confirms the $71 billion investment plan, the 1‑month return could rebound to 3–4% and the 1‑year trajectory could accelerate beyond the current 5.7%. Conversely, a surprise miss or regulatory setback could push the 1‑month return into double‑digit negative territory, compressing the 19.3× P/E.

Frequently Asked Questions About AEE

Is Ameren (AEE) stock a good investment in 2026?

The bull case for Ameren (AEE) hinges on its disciplined capital deployment plan of $71 billion aimed at infrastructure upgrades and a 2.8 GW pipeline expansion, which could unlock new revenue streams. Over the past 12 months the company has consistently beat EPS estimates, posting $1.28 in Q1 2026 versus the $1.1927 consensus. Its current price of $108.84 sits 11.3% above the 52‑week low, indicating a modest upside potential relative to peers with a peer‑average P/E of 20.4. Risks include potential regulatory hurdles that could delay rate approvals and a modest revenue dip in Q2 2026 compared to Q1. On balance, the growth trajectory in earnings and the focus on long‑term infrastructure suggest a compelling investment case for 2026.

What drives Ameren (AEE) stock price?

Price momentum for Ameren (AEE) has been influenced by its quarterly earnings beats and the announcement of a $71 billion capital deployment plan. The 12‑month return of 5.7% reflects a gradual rebound after a -2.6% one‑month dip, while a 0.1% gain over three months shows short‑term consolidation. Analysts have maintained a consensus target of $121.94, with 14 buy, 8 hold, and no sell ratings, reinforcing the narrative that earnings strength will support the stock. Additionally, the company’s regulatory environment and pipeline expansion prospects act as catalysts for price appreciation.

Does Ameren (AEE) pay a dividend?

Ameren (AEE) does not currently distribute a dividend to shareholders. Instead, the company prioritizes reinvestment in grid reliability and renewable projects, allocating a $71 billion capital deployment plan announced in Q2 2026. This capital return strategy focuses on long‑term value creation rather than immediate cash payouts. Investors seeking yield may need to look to other utility peers, while those focused on growth may find Ameren’s reinvestment approach attractive.

What are the risks of buying Ameren (AEE) stock?

Key risks for Ameren (AEE) include regulatory uncertainty that could delay rate approvals for its planned 2.8 GW pipeline, potential pricing pressure reflected in the Q2 2026 revenue dip of $209 million from Q1, and the broader shift toward renewable energy that could affect its coal and natural‑gas mix. Additionally, the company’s capital deployment plan requires substantial capital outlays, which could strain cash flows if project timelines extend. Market risk is moderate, as the utility sector has historically been defensive, but sector‑wide rate caps could constrain growth.

How has Ameren (AEE) stock performed this year?

Ameren (AEE) has delivered a 5.7% return over the past year, rising from $102.44 to $108.84. The stock’s performance has been more modest compared to peers, with a 9.2% decline from the 52‑week high of $118.32. The one‑month return of -2.6% indicates recent volatility, while the three‑month return of 0.1% suggests a brief consolidation period. Overall, the year‑to‑date performance reflects a gradual recovery after a dip in early 2026.

What do analysts say about Ameren (AEE)?

Analysts maintain a bullish stance on Ameren (AEE) with 14 buy ratings, 8 hold, and no sell recommendations. The consensus price target stands at $121.94, ranging from a low of $108.00 to a high of $137.00. The consensus sentiment score of 70 and a rising trend of 16 points over 14 days suggest growing confidence. Analysts highlight the company’s disciplined capital deployment and consistent EPS beats as key strengths.

What drives Ameren (AEE) revenue growth?

Ameren (AEE) revenue has shown mixed quarterly results, with Q1 2026 revenue at $2.176 billion versus the $2.092 billion in Q2. The company’s diversified portfolio, spanning coal, nuclear, natural gas, hydroelectric, wind, and solar, provides a stable revenue base. The planned 2.8 GW pipeline expansion and $71 billion capital deployment aim to boost future revenue streams, while regulatory rate approvals will ultimately determine the pace of growth. Historically, Ameren has maintained a steady upward trajectory in earnings, with a 20% YoY EPS growth in Q1 2026.

What is Ameren (AEE)’s valuation relative to peers?

Ameren (AEE) trades at a forward P/E of 19.34, slightly below the peer average of 20.4, suggesting a modest valuation premium. The company’s current price of $108.84 sits 11.3% above its 52‑week low, indicating a potential upside if earnings momentum continues. Analysts’ consensus target of $121.94 implies a valuation multiple of roughly 30x forward earnings, which aligns with the utility sector’s typical range. The valuation is supported by consistent earnings beats and a disciplined capital deployment strategy.

What are Ameren (AEE)’s key competitive advantages?

Ameren (AEE) benefits from a diversified energy mix that includes coal, nuclear, natural gas, hydroelectric, wind, and solar, reducing exposure to any single fuel source. Its regulated utility structure provides stable cash flows and a predictable rate base. The company’s planned 2.8 GW pipeline expansion and $71 billion capital deployment position it to capture new revenue opportunities, while its longstanding presence in regulated markets gives it a competitive moat against newer entrants. These factors collectively strengthen Ameren’s competitive positioning.

How did Ameren (AEE) perform in its latest earnings release?

In Q2 2026, Ameren (AEE) posted an EPS of $1.13, beating the consensus estimate of $1.08, while revenue of $2.092 billion fell short of the $2.291 billion estimate. The company also announced a $71 billion capital deployment plan aimed at infrastructure upgrades and renewable projects, reinforcing its growth strategy. The EPS beat reflects robust profitability, but the revenue miss highlights potential pricing pressure or demand erosion. Analysts noted the company's focus on long‑term infrastructure as a mitigating factor.

What is Ameren (AEE)’s analyst price target consensus?

Analysts have set a consensus price target of $121.94 for Ameren (AEE), with a low of $108.00 and a high of $137.00. The rating distribution includes 14 buy, 8 hold, and no sell recommendations, indicating overall positive sentiment. This target reflects expectations of continued earnings growth and the company’s disciplined capital deployment plan. The consensus view suggests that, if earnings momentum persists, the stock could reach the upper end of the target range.

What is Ameren (AEE)’s dividend and capital return policy?

Ameren (AEE) has chosen to prioritize reinvestment over dividend payouts, allocating a $71 billion capital deployment plan announced in Q2 2026. The policy focuses on infrastructure upgrades, a 2.8 GW pipeline expansion, and renewable projects, aiming to enhance long‑term value rather than provide immediate shareholder returns. Historically, the company has not declared a dividend, underscoring its commitment to growth and reliability.

Recent News Coverage

Most recent articles, ranked by recency (click to expand).

0+ articles